Cigna price target lowered to $350 from $400 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is confident that Cigna can correct their stop-loss pricing ...
The Cigna Group (NYSE:CI) Shares Gap Down on Disappointing Earnings
Shares of The Cigna Group (NYSE:CI – Get Free Report) gapped down prior to trading on Thursday after the company announced weaker than expected quarterly earnings. The stock had previously closed at ...
Managed Healthcare Executive21h
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.
Managed Healthcare Executive21h
Cigna's 2024 Revenue Increase Driven by Evernorth's Strong Performance
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...